Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 1998

View Archived Issues

Elan issues further update on development pipeline

Ibex: Q1 1999 highlights

Company Profile: Oxagen

Millennium delivers two additional drug targets for screening to Lilly

PathoGenesis reports encouraging phase II results for TOBI in bronchiectasis

Cambridge NeuroScience and Bayer to collaborate on GGF2 development

Immune Response announces phase IIb trial results for RA

Lilly develops novel 5-HT1A/5-HT1D antagonists for smoking cessation and CNS disorders

New series of 5-ht1F agonists disclosed by Lilly

Somatostatin agonists from Takeda claimed for diabetes and its complications

Patent assigned to Sumitomo describes new compounds for immune and inflammatory disorders

HSP-117: newly synthesized NK1 receptor antagonist with potent antiemetic effects

Disposition of L-732351, a semisynthetic macrolide immunosuppressant, in animals

Japanese approval sought for Accolate

Orphan drug status given to Immunomedics' CEA-Cide pancreatic cancer therapeutic

Design of potent MAP kinase p38 inhibitors reported by R.W. Johnson

Knoll and Hoechst Marion Roussel to codevelop treatment for CHF and hypertension

Another novel class of nonsteroidal progesterone receptor agonists designed by Ligand

FDA accepts Hyal's NDA for Solarase

Allelix and Lilly extend drug discovery alliance focusing on several therapeutic areas

Preliminary phase II results for Incel + paclitaxel in refractory breast cancer

Y5 antisense ODN used to confirm involvement of this receptor in the regulation of feeding

New cancer-linked gene licensed by Corixa from MIT

Oral human immunoglobulin proves to be safe and effective treatment for RA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...